John H Friedman
CIK 1067915 · last filed 2013-11-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CSII price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
WOODBURY, NY 11797
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Cardiovascular Systems Inc (CSII) Delisted | Director | 174,112 | $20.00 | $3.48M | -$7.74M | 22 | 2013-11-12 |
| COMVERSE TECHNOLOGY INC/NY/ (CMVT) Delisted | Director | — | — | — | $0 | 1 | 2007-03-30 |
| CONOR MEDSYSTEMS INC (CONR) Delisted | Director | 0 | — | — | $0 | 1 | 2007-02-02 |
| RENOVIS INC (RNVS) Delisted | Director | — | — | — | $0 | 1 | 2007-01-30 |
Recent Filings · Page 2 of 3
27 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-01-13 | Cardiovascular Systems Inc (CSII) Delisted | Sell (S) | −17,532 | -$182.8K | EDGAR |
| 2012-01-11 | Cardiovascular Systems Inc (CSII) Delisted | Sell (S) | −27,000 | -$281.3K | EDGAR |
| 2012-01-09 | Cardiovascular Systems Inc (CSII) Delisted | Sell (S) | −34,992 | -$364.3K | EDGAR |
| 2012-01-05 | Cardiovascular Systems Inc (CSII) Delisted | Sell (S) | −52,398 | -$532.6K | EDGAR |
| 2011-11-30 | Cardiovascular Systems Inc (CSII) Delisted | Sell (S) | −25,000 | -$250.3K | EDGAR |
| 2011-09-09 | Cardiovascular Systems Inc (CSII) Delisted | Exer (X) | +44,688 | $392.4K | EDGAR |
| 2011-08-10 | Cardiovascular Systems Inc (CSII) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-08-17 | Cardiovascular Systems Inc (CSII) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-04-23 | Cardiovascular Systems Inc (CSII) Delisted | Mixed | — | $0 | EDGAR |
| 2009-11-06 | Cardiovascular Systems Inc (CSII) Delisted | Buy (P) | +8,000 | $32.5K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.